首页> 外国专利> a transmembranprotein kodierendes human autism suszeptibilitu00e4tsgen and its use

a transmembranprotein kodierendes human autism suszeptibilitu00e4tsgen and its use

机译:跨膜蛋白kodierendes对人类自闭症的影响及其应用

摘要

The present invention discloses the identification of a human autism susceptibility gene, which can be used for the diagnosis, prevention and treatment of autism and related disorders, as well as for the screening of therapeutically active drugs. The invention more specifically discloses that the ATP2B2 gene on chromosome 3 and certain alleles thereof are related to susceptibility to autism and represent novel targets for therapeutic intervention. The present invention relates to particular mutations in the ATP2B2 gene and expression products, as well as to diagnostic tools and kits based on these mutations. The invention can be used in the diagnosis of predisposition to, detection, prevention and/or treatment of Asperger syndrome, pervasive developmental disorder, childhood disintegrative disorder, mental retardation, anxiety, depression, attention deficit hyperactivity disorders, speech delay or language impairment, epilepsy, metabolic disorder, immune disorder, bipolar disease and other psychiatric and neurological diseases including schizophrenia.
机译:本发明公开了人自闭症易感基因的鉴定,其可用于自闭症和相关疾病的诊断,预防和治疗,以及用于筛选治疗活性药物。本发明更具体地公开了3号染色体上的ATP2B2基因及其某些等位基因与对自闭症的敏感性有关,并且代表了治疗干预的新靶标。本发明涉及ATP2B2基因和表达产物中的特定突变,以及基于这些突变的诊断工具和试剂盒。本发明可以用于诊断,检测,预防和/或治疗阿斯伯格综合症,普遍的发育障碍,儿童崩解性障碍,智力低下,焦虑,抑郁,注意力缺陷多动障碍,语言障碍或语言障碍,癫痫的易感性诊断。 ,代谢紊乱,免疫紊乱,躁郁症和其他精神疾病和神经疾病,包括精神分裂症。

著录项

  • 公开/公告号DE602006017045D1

    专利类型

  • 公开/公告日2010-11-04

    原文格式PDF

  • 申请/专利权人 INTEGRAGEN;

    申请/专利号DE20066017045T

  • 申请日2006-03-23

  • 分类号C12Q1/68;

  • 国家 DE

  • 入库时间 2022-08-21 18:27:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号